CURIS, INC. Accrued Liabilities, Current
CURIS, INC. (CRIS) had Accrued Liabilities, Current of $7.24 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $7.24M.
- 2026-03-31: Accrued Liabilities, Current $7.00M.
- 2025-12-31: Accrued Liabilities, Current $7.27M.
- 2025-09-30: Accrued Liabilities, Current $7.29M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.24M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $7.00M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.27M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $7.29M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $6.66M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $6.48M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $7.11M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $8.14M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $6.74M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $6.33M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $9.04M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $7.22M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $5.78M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $4.25M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $5.68M 10-K · filed 2024-02-08 | |
| 2022-09-30 | $6.88M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.58M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $4.59M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $6.34M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $5.31M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $3.18M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $2.06M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $3.63M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $2.74M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $2.10M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.72M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $1.91M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $1.83M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.57M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.42M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $3.46M 10-K · filed 2020-03-19 | |
| 2018-09-30 | $3.30M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $3.26M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.98M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $2.79M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $2.53M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $2.48M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.57M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $2.73M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $2.32M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $2.01M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.52M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.93M 10-K · filed 2017-03-09 | $1.93M 10-K · filed 2016-02-29 |
| 2015-09-30 | $1.87M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.82M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.36M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $2.01M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $1.94M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.51M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.25M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $1.91M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $1.98M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.42M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.15M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.47M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $1.29M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.06M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.13M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $1.42M 10-K · filed 2013-03-13 | |
| 2011-09-30 | $1.15M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $701.11K 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $854.61K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |